{"id":4644,"date":"2020-09-12T17:32:10","date_gmt":"2020-09-12T16:32:10","guid":{"rendered":"https:\/\/thedailyleaks.com\/?p=4644"},"modified":"2020-09-12T17:32:10","modified_gmt":"2020-09-12T16:32:10","slug":"oxford-resumes-astrazeneca-covid-19-vaccine-trial-halted-by-patient-illness","status":"publish","type":"post","link":"https:\/\/thedailyleaks.com\/oxford-resumes-astrazeneca-covid-19-vaccine-trial-halted-by-patient-illness\/","title":{"rendered":"Oxford resumes AstraZeneca COVID-19 vaccine trial halted by patient illness"},"content":{"rendered":"
The pharmaceutical giant, AstraZeneca, has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after receiving the green light from safety watchdogs, the company said on Saturday.<\/p>\n
The late-stage trials of the experimental vaccine, developed with researchers from the University of Oxford, were suspended this week after an illness in a study subject in Britain, casting doubts on an early rollout.<\/p>\n
\u201cOn 6 September, the standard review process triggered a voluntary pause to vaccination across all global trials to allow review of safety data by independent committees, and international regulators,\u201d AstraZeneca said.<\/p>\n
It added that safety reviewers had recommended to Britain\u2019s Medicines Health Regulatory Authority (MHRA) that it was safe to resume the UK trials.<\/p>\n
ALSO READ:\u00a0<\/strong>COVID-19: Hydroxychloroquine could save up to 100,000 lives, Yale epidemiology professor says<\/a><\/strong><\/p>\n The patient involved in the study had been reportedly suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.<\/p>\n AstraZeneca, based in Cambridge, said it could not disclose further medical information.<\/p>\n Governments around the world are desperate for a vaccine to help end the pandemic, which has caused more than 900,000 deaths and global economic turmoil. The World Health Organization (WHO) had flagged AstraZeneca\u2019s as the most promising.<\/p>\n The pause of the trials came after reports that the United States was aiming for fast-track authorization or approval of a vaccine before November\u2019s presidential election.<\/p>\n Leading U.S. and European vaccine developers have pledged to uphold scientific safety and efficacy standards for their experimental vaccines and not bow to political pressures to rush the process.<\/p>\n AstraZeneca has already agreed to supply close to three billion doses to governments across the globe – more than any other vaccine project.<\/p>\n The WHO\u2019s chief scientist said the pause in the trial should serve as a \u201cwake-up\u201d call that there would be ups and downs in the development of a vaccine.<\/p>\n","protected":false},"excerpt":{"rendered":" The pharmaceutical giant, AstraZeneca, has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after receiving the green light from safety watchdogs, the company said on Saturday. The late-stage […]<\/a><\/p>\n<\/div>","protected":false},"author":2,"featured_media":4645,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[18,3,2],"tags":[895,68,896],"coauthors":[25],"class_list":{"0":"post-4644","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"category-latest-news","9":"category-top-news","10":"tag-astrazeneca","11":"tag-covid-19","12":"tag-oxford"},"yoast_head":"\n